Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

This Healthcare Fund Thinks Large-Caps Are The Best Way To Go

Page 1 of 2

HealthInvest Partners AB, led by Anders Hallberg and Carl Bennet, was founded back in 2006 with the purpose of investing in healthcare companies that are leaders in their market segments. Hence, it goes without saying that the fund’s strategy avoids risky bets on stocks, whose companies are in the early stages of clinical experiments and possess high risk. The fund employs a wide range of in-house research techniques to select companies which are trading at a discount or show stable free cash flows, since its managers prefer to target long-term investments. Thus, while HealthInvest Partners generally prefers small-cap stocks, as Anders Hallberg and Carl Bennet believe in the informational advantage gained through investing in less well-known companies, it’s not surprising to find that their top picks as of June 30 are actually in large-cap stocks. We’ll look at those top three positions of the fund, which are in Pfizer Inc (NYSE:PFE), Gilead Sciences Inc (NASDAQ:GILD), and Anthem Inc (NYSE:ANTM), in this article, and attempt to discern what makes them stand out to the fund.

Hospital Corporation hospital stocks CYH HCA THC UHS patient, corridor, doctor, bed, care, clinic

Spotmatik Ltd /

We pay attention to hedge funds’ moves because our research has shown that hedge funds are extremely talented at picking stocks on the long side of their portfolios. It is true that hedge fund investors have been underperforming the market in recent years. However, this was mainly because hedge funds’ short stock picks lost a ton of money during the bull market that started in March 2009. Hedge fund investors also paid an arm and a leg for the services that they received. We have been tracking the performance of hedge funds’ 15 most popular stock picks in real time since the end of August 2012. These stocks have returned 139% since then and outperformed the S&P 500 Index by around 81 percentage points (see the details here). That’s why we believe it is important to pay attention to hedge fund sentiment; we also don’t like paying huge fees.

Anders Hallberg And Carl Bennet
Anders Hallberg And Carl Bennet
HealthInvest Partners AB

According to the fund’s latest 13F filings for the June 30 reporting period, it holds around 846,000 shares of Pfizer Inc (NYSE:PFE) valued at $28.98 million. Over the second quarter the $210.96 billion pharmaceutical giant, which is engaged in the development and manufacturing of medical products, has lost around 3.6% of its value. Nevertheless, HealthInvest saw an opportunity in such a price movement and added an additional 60.22% to its previous position. The company is scheduled to report its second quarter earnings on July 28, and analysts expect the company to show EPS and revenue declines of 10% and 8% respectively on a year-over-year basis. Within our database, Ken Fisher’s Fisher Asset Management tops the list of the largest shareholders of Pfizer Inc (NYSE:PFE) which have filed for the June 30 reporting period, owning 31.82 million shares valued at $1.07 billion at the end of the second quarter.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!